Peter Hulick, MD, Division Head, Center for Medical Genetics
Dr. Peter J. Hulick is the Division Head and a medical geneticist at the NorthShore University HealthSystem Center for Medical Genetics and a Clinical Assistant Professor at the University of Chicago Pritzker School of Medicine.
Dr. Hulick completed his clinical medical genetics residency at Harvard Medical School where his clinical concentrations included connective tissue diseases such as Marfan syndrome and Ehlers-Danlos syndrome while also maintaining a general genetics clinic.
His research during his Harvard genetics training consisted of identifying potential biomarkers of kidney cancer through gene expression profiling of tumor cell lines and the development of a clinical assay to detect kidney cancer at an early stage. He also studied the biological function of the folliculin gene product which, when mutated, causes the kidney cancer predisposition syndrome Birt-Hogg-Dube. During his medical genetics residency, he graduated with a masters in medical science degree from the Harvard Medical Scholars in Clinical Science program which trains individuals for careers in clinical research.
Dr. Hulick received his undergraduate degree in biology from Northwestern University in Evanston, IL and his medical degree from Jefferson Medical College, in Philadelphia, PA. He completed an internal medicine residency at Mayo Clinic, Jacksonville, FL before pursuing his clinical medical genetics training in Boston. Dr. Hulick is board certified in Internal Medicine and Clinical Genetics.
His clinical interests, in addition to general genetic syndromes, include connective tissue disease, cardiovascular, and kidney cancer genetics.
Shashanna Ndong, MD, Medical Geneticist, Center for Medical Genetics
Dr. Shashanna Ndong is a medical geneticist at the NorthShore Center for Medical Genetics and a Clinical Educator at the University of Chicago School of Medicine.
Dr. Ndong completed her medical genetics training at the Icahn School of Medicine at Mount Sinai Medical Center in New York City. Her research included analysis of the effect of variants of uncertain significance in BRCA1 and BRCA2 on patient management decisions. She also participated in a retrospective analysis of the ophthalmologic findings in individuals with Fabry disease and studied the natural history of recurrent copy number variants. She completed residency at the University of Illinois at Chicago and is board certified in Internal Medicine and Pediatrics.
Her professional interests include congenital hearing loss, cardiovascular genetic disorders, and neurogenetic disorders in both adult and pediatric populations.